HHS – Page 3 – medicarereport.org

Friday, December 27, 2024

Latest:

Eileen Cook June 12, 2023June 12, 2023 0 Comments Average Sales Price (ASP), CMS, HHS, Medicare Part B, The Inflation Reduction Act, The Medicare Prescription Drug Inflation Rebate Program

Inflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation

(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of

HHS Medicare - General Telehealth

Eileen Cook May 11, 2023May 11, 2023 0 Comments COVID-19, HHS, medicare, Telehealth

Medicare telehealth flexibilities to remain in place until 2024

(By Naomi Diaz for Becker’s Hospital Review) The COVID-19 public health emergency is set to expire on May 11, but

Health Care Finance HHS Medicare - General Part D/Prescription Drugs

Eileen Cook April 11, 2023April 11, 2023 0 Comments HHS, Inflation Reduction Act of 2022, Medicare Part B, Medicare Part B drugs, Rebates

HHS cuts 7 drugs from Medicare Part B rebates list

(By Rylee Wilson for Becker’s Hospital Review) HHS has removed seven drugs from its initial list of 27 drugs subject

Health Care Finance HHS Part D/Prescription Drugs

Eileen Cook March 28, 2023March 28, 2023 0 Comments AHIP, Copay coupons, HHS, Out-of-network charges

AHIP backs HHS in challenge to agency’s copay coupon policies

(By Rylee Wilson for Becker’s Hospital Review) AHIP is backing an HHS policy that allows insurers not to count copay

CMS Health Care Finance Health Care Redesign HHS Medicare - General Medicare Advantage

Eileen Cook March 23, 2023March 23, 2023 0 Comments CMS, HHS, Lobbying, Medicare Advantage, Rate Changes

Payers spending ‘buckets of money’ lobbying against Medicare Advantage rate changes

(By Rylee Wilson for Becker’s Hospital Review) The insurance industry is mounting its largest lobbying fight in years against CMS’

CMS Health Care Redesign HHS Part D/Prescription Drugs

Eileen Cook March 20, 2023March 20, 2023 0 Comments CMS, HHS, Medicare Drug Price Negotiation Program

HHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026

(Source – www.cms.gov) For the first time in history, Medicare will have the ability to negotiate lower prescription drug prices

Affordable Care Act (ACA)HHS M4A and Public Option Plans

Eileen Cook February 24, 2023February 24, 2023 0 Comments ACA, CDC, East Palestine, EPA, HHS, Medicare for All

Medicare for all … of East Palestine?

(By Sarah Owermohle for STAT) WASHINGTON — Nearly three weeks after a train derailed in East Palestine, Ohio, spewing toxic

CMS HHS Medicare Advantage

Eileen Cook February 21, 2023February 21, 2023 0 Comments audits, CMS, Funding Cuts, HHS, Medicare Advantage, Risk Adjustment Rules

HHS: Medicare Advantage audits, risk adjustment changes are not funding cuts

(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage audits are “unequivocally not cuts” in funding, HHS says. In a Feb.

Aging Health Care - General HHS Medicare - General Part D/Prescription Drugs

Arlene Sharp February 15, 2023February 15, 2023 0 Comments HHS, Medicare Part D, Prescription drug coverage

HHS unveils 3 new drug price models

By Mackenzie Bean and Paige Twenter On February 14, 2023 for Becker’s Hospital Review HHS is taking aim at high

CMS Medicare Advantage Mental Health/Behavioral Health Part D/Prescription Drugs

Eileen Cook December 16, 2022December 16, 2022 0 Comments Behavioral Health, CMS, HHS, Medicare Advantage, Medicare Part D

HHS Proposes Rule to Strengthen Beneficiary Protections, Improve Access to Behavioral Health Care, and Promote Equity for Millions of Americans with Medicare Advantage and Medicare Part D

(Source – www.cms.gov) The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services